4:44 PM
 | 
Nov 11, 2013
 |  BC Extra  |  Politics & Policy

FTC to examine state legislation, naming for biosimilars

The U.S. Federal Trade Commission is examining how state regulations and international naming conventions could affect the development of and competition for biosimilars. A Dec. 10 workshop will cover the topics...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >